Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study

被引:5
|
作者
Azumi, Motoi
Suda, Takeshi
Terai, Shuji
Akazawa, Kouhei
机构
[1] Department of Medical Informatics, Graduate School of Medical and Dental Sciences
[2] Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital
[3] Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University
[4] Department of Medical Informatics, Niigata University Medical and Dental Hospital
关键词
hepatocellular carcinoma; indocyanine green plasma disappearance rate; nomogram; radiofrequency ablation; des-gamma-carboxy prothrombin; LIVER-CANCER; RESECTION; SURVIVAL; PREDICTION; MANAGEMENT; DIAGNOSIS; THERAPY; SYSTEM;
D O I
10.2169/internalmedicine.56.7278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Radiofrequency ablation has been used widely for the local ablation of hepatocellular carcinoma, particularly in its early stages. The study aim was to identify significant prognostic factors and develop a predictive nomogram for patients with hepatocellular carcinoma who have undergone radiofrequency ablation. We also developed the formula to predict the probability of 3- and 5-year overall survival based on clinical variables. Methods We retrospectively studied 96 consecutive patients with hepatocellular carcinoma who had undergone radiofrequency ablation as a first-line treatment. Independent and significant factors affecting the overall survival were selected using a Cox proportional hazards model, and a prognostic nomogram was developed based on these factors. The predictive accuracy of the nomogram was determined by Harrell's concordance index and compared with the Cancer of the Liver Italian Program score and Japan Integrated Staging score. Results A multivariate analysis revealed that age, indocyanine green plasma disappearance rate, and log (des-gamma-carboxy prothrombin) level were independent and significant factors influencing the overall survival. The nomogram was based on these three factors. The mean concordance index of the nomogram was 0.74 +/- 0.08, which was significantly better than that of conventional staging systems using the Cancer of the Liver Italian Program score (0.54 +/- 0.03) and Japan Integrated Staging score (0.59 +/- 0.07). Conclusion This study suggested that the indocyanine green plasma disappearance rate and age at radiofrequency ablation (RFA) and des-gamma-carboxy-prothrombin (DCP) are good predictors of the prognosis in hepatocellular carcinoma patients after radiofrequency ablation. We successfully developed a nomogram using obtainable variables before treatment.
引用
收藏
页码:1001 / 1007
页数:7
相关论文
共 50 条
  • [11] Prognostic Factors of Radiofrequency Ablation for Hepatocellular Carcinoma: A Nationwide Cohort Study
    Lee, Teng-Yu
    Ho, Hsiu-Jon
    Kuo, Ken N.
    Lin, Jaw-Town
    Lane, Hsien-Yuan
    Wu, Ming-Shiang
    Wu, Chun-Ying
    [J]. HEPATOLOGY, 2013, 58 : 1245A - 1245A
  • [12] Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma
    Tang, Tengqian
    Feng, Xiaobin
    Yan, Jun
    Xia, Feng
    Li, Xiaowu
    Ma, Kuansheng
    Bie, Ping
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2014, 30 (06) : 402 - 407
  • [13] Prognostic Factors in Hepatitis C Patients with a Single Small Hepatocellular Carcinoma after Radiofrequency Ablation
    Toshikuni, Nobuyuki
    Takuma, Yoshitaka
    Goto, Tomoyuki
    Yamamoto, Hiroshi
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2361 - 2366
  • [14] Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure
    Uta Merle
    Olivia Sieg
    Wolfgang Stremmel
    Jens Encke
    Christoph Eisenbach
    [J]. BMC Gastroenterology, 9
  • [15] Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure
    Merle, Uta
    Sieg, Olivia
    Stremmel, Wolfgang
    Encke, Jens
    Eisenbach, Christoph
    [J]. BMC GASTROENTEROLOGY, 2009, 9
  • [16] Incomplete Ablation After Radiofrequency Ablation of Hepatocellular Carcinoma: Analysis of Risk Factors and Prognostic Factors
    Vincent Wai-To Lam
    Kelvin K. Ng
    Kenneth Siu-Ho Chok
    Tan-To Cheung
    Jimmy Yuen
    Helen Tung
    Wai-Kuen Tso
    Sheung-Tat Fan
    Ronnie T. P. Poon
    [J]. Annals of Surgical Oncology, 2008, 15 : 782 - 790
  • [17] Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: Analysis of risk factors and prognostic factors
    Lam, Vincent Wai-To
    Ng, Kelvin K.
    Chok, Kenneth Siu-Ho
    Cheung, Tan-To
    Yuen, Jimmy
    Tung, Helen
    Tso, Wai-Kuen
    Fan, Sheung-Tat
    Poon, Ronnie T. P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) : 782 - 790
  • [18] Radiofrequency ablation for recurrent hepatocellular carcinoma in postresectional patients: prognostic factors analysis
    Lin, Yen-Huai
    Chiou, Yi-You
    Chou, Yi-Hong
    Chau, Gar-Yang
    Wang, Hsin-Kai
    Chiang, Jen-Huey
    Chang, Cheng-Yen
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1239 - 1244
  • [19] Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
    Kim, Chang Gon
    Lee, Hyun Woong
    Choi, Hye Jin
    Lee, Jung Il
    Lee, Hye Won
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Han Sang
    Kim, Kyung Hwan
    Choi, Seong Jin
    Kim, Yongun
    Lee, Kwan Sik
    Kim, Gyoung Min
    Kim, Man Deuk
    Won, Jong Yoon
    Lee, Do Yun
    Kim, Beom Kyung
    [J]. CANCER MEDICINE, 2019, 8 (11): : 5023 - 5032
  • [20] Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study
    Abd El-Fattah, Mohamed
    Aboelmagd, Mohamed
    Elhamouly, Mohammed
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (02) : 227 - 235